Exane Derivatives’s Wyndham Hotels & Resorts WH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5
Closed -$423 1011
2022
Q1
$423 Buy
+5
New +$426 ﹤0.01% 887
2021
Q4
Sell
-5
Closed -$386 1060
2021
Q3
$386 Hold
5
﹤0.01% 969
2021
Q2
$354 Hold
5
﹤0.01% 978
2021
Q1
$349 Hold
5
﹤0.01% 831
2020
Q4
$297 Hold
5
﹤0.01% 776
2020
Q3
$252 Hold
5
﹤0.01% 716
2020
Q2
$213 Hold
5
﹤0.01% 653
2020
Q1
$158 Hold
5
﹤0.01% 665
2019
Q4
$301 Hold
5
﹤0.01% 641
2019
Q3
$259 Hold
5
﹤0.01% 617
2019
Q2
$279 Hold
5
﹤0.01% 621
2019
Q1
$250 Hold
5
﹤0.01% 564
2018
Q4
$227 Hold
5
﹤0.01% 627
2018
Q3
$281 Hold
5
﹤0.01% 592
2018
Q2
$294 Buy
+5
New +$308 ﹤0.01% 584

Other funds holding WH

Exane Derivatives's WH Position: Q2 2022 in Review

Exane Derivatives sold out of Wyndham Hotels & Resorts (WH) in Q2 2022, closing a stake of 5 shares — an estimated $423 sold.

Exane Derivatives first reported a position in WH in Q2 2018 and held it in 15 quarters. The position peaked at $423 in Q1 2022. 396 funds tracked by Wall St. Rank hold WH as of Q2 2022.

  • Exane Derivatives reported no remaining Wyndham Hotels & Resorts position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 5 Wyndham Hotels & Resorts shares in Q2 2022, an estimated $423.
  • Exane Derivatives first reported a position in Wyndham Hotels & Resorts in Q2 2018 and held it in 15 quarters.
  • Exane Derivatives's Wyndham Hotels & Resorts position peaked at $423 in Q1 2022.
  • 396 funds tracked by Wall St. Rank held Wyndham Hotels & Resorts as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.